Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 203

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy

Höglinger, Günter U., Lannuzel, Annie, Khondiker, Myriam Escobar, Michel, Patrick P., Duyckaerts, Charles, Féger, Jean, Champy, Pierre, Prigent, Annick, Medja, Fadia, Lombes, Anne, Oertel, Wolfgang H., Ruberg, Merle, Hirsch, Etienne C.·2005·Journal of Neurochemistry

Abstract

Reduced activity of the mitochondrial respiratory chain – particularly complex I – may be implicated in the etiology of both Parkinson's disease and progressive supranuclear palsy, although these neurodegenerative diseases differ substantially as to their distinctive pattern of neuronal cell loss and the predominance of cerebral α‐synuclein or tau protein pathology. To determine experimentally whether chronic generalized complex I inhibition has an effect on the distribution of α‐synuclein or tau, we infused rats systemically with the plant‐derived isoflavonoid rotenone. Rotenone‐treated rats with a pronounced metabolic impairment had reduced locomotor activity, dystonic limb posture and postural instability. They lost neurons in the substantia nigra and in the striatum. Spherical deposits of α‐synuclein were observed in a few cells, but cells with abnormal cytoplasmic accumulations of tau immunoreactivity were significantly more numerous in the striatum of severely lesioned rats. Abnormally high levels of tau immunoreactivity were found in the cytoplasm of neurons, oligodendrocytes and astrocytes. Ultrastructurally, tau‐immunoreactive material consisted of straight 15‐nm filaments decorated by antibodies against phosphorylated tau. Many tau+ cell bodies also stained positive for thioflavin S, nitrotyrosine and ubiquitin. Some cells with abnormal tau immunoreactivity contained activated caspase 3. Our data suggest that chronic respiratory chain dysfunction might trigger a form of neurodegeneration in which accumulation of hyperphosphorylated tau protein predominates over deposits of α‐synuclein.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2005.03493.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 203

Metadata

Authors
Höglinger, G. U., Lannuzel, A., Khondiker, M. E., Michel, P. P., Duyckaerts, C., Féger, J., Champy, P., Prigent, A., Medja, F., Lombes, A., Oertel, W. H., Ruberg, M., & Hirsch, E. C.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2005-10-10
Volume
95
Issue
4
Pages
930-939
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2032421019
Cited by
203
References
5
FWCI
4.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. https://app.cochat.ai/papers/10.1111/j.1471-4159.2005.03493.x
The paper
Höglinger, G. U., Lannuzel, A., Khondiker, M. E., Michel, P. P., Duyckaerts, C., Féger, J., Champy, P., Prigent, A., Medja, F., Lombes, A., Oertel, W. H., Ruberg, M., & Hirsch, E. C. (2005). The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2005.03493.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.